troubleshootTroubleshooting Guide

Week 8 and Still No Loss

Two months in, the side effects have faded and the scale still hasn't budged. That is more common than the success stories suggest. Here is what to look at next.

Week 8 is when most people expect tangible results. Side effects have usually settled, the medication routine feels normal, and the early novelty has worn off. If the scale has barely moved, the disappointment can be sharp — especially against the backdrop of stories online that describe ten or fifteen pounds gone by now.

The reality is that weight loss curves in the major GLP-1 trials show modest, not dramatic, average loss by week 8. People are still in titration. The medication is still building toward its full effect. Behavior, sleep, and protein matter more during these middle weeks than they will at any other point.

A truly flat scale at week 8 is uncommon but not catastrophic. Most of the time it traces back to a small number of identifiable causes — and most of those are fixable with one conversation and one or two specific changes.

Is this normal?

Partly. Trial data shows average weight loss of roughly 3 to 6 percent of starting body weight by week 8 in both STEP 1 and SURMOUNT-1. That means a 200-pound person typically loses around 6 to 12 pounds by this point, on average. But "average" includes wide variation. Some people lose nothing by week 8 and then lose 15 percent by month 12. Some people lose quickly and plateau early. The trial curves only tell you what the typical person experiences.

At week 8 you are also still climbing the dose ladder. Semaglutide titration usually reaches 1.0 mg around week 9, not the full 2.4 mg until week 17. Tirzepatide titration reaches 5 mg around week 8 and does not reach 10 mg or higher until later. So a flat scale at week 8 may simply mean you have not yet reached a dose where weight loss accelerates.

That said, completely flat for eight weeks is worth investigating. Below are the patterns that explain most cases.

Why this happens

The most common causes

vaccines

Still on a low titration dose

If you are at 0.25 mg or 0.5 mg semaglutide, or 2.5 mg tirzepatide, you are below typical weight-loss doses. The next step usually changes the picture.

restaurant

Intake never actually dropped

Some people feel less hungry but still eat the same volumes by habit. A five-day food log usually reveals this within the first day or two.

local_bar

Liquid calories and alcohol

Smoothies, lattes, juices, and weekly drinks add up fast. Liquid calories are the most common hidden source at week 8.

bedtime

Short or broken sleep

Less than seven hours of sleep raises hunger hormones and reduces willpower. It quietly stalls many week 8 plans.

fitness_center

No protein, no lifting

Without enough protein and any resistance training, early loss tends to be water and lean mass — which the scale can hide entirely.

medical_services

Medical contributors

Hypothyroidism, certain medications, and PCOS can all dampen GLP-1 response. Worth a brief check with your provider.

What you can do this week

Confirm where you are in the dose ladder. If you are still on a titration dose and tolerating it, ask your provider whether stepping up is appropriate. Do not change the dose on your own.

Run a five-day food log including bites, sips, drinks, and weekend meals. Track protein specifically — aim for 0.7 to 1.0 grams per pound of goal body weight, spread across the day. Many people who think nothing has changed find a clear gap here within three days.

Add two short resistance training sessions per week. Even 20-minute bodyweight workouts protect lean mass and support metabolic rate. Walking is fine for adherence, but it does not replace lifting for body composition.

Sleep seven to nine hours. Pause alcohol for two weeks. Drink a full glass of water before each meal. These are unglamorous and they consistently move the scale in week 8 holdouts.

When to talk to your provider

Common Concerns

Should I expect weight loss by week 8?expand_more

Most people see some loss — average around 3 to 6 percent of starting body weight in trial data — but not everyone. A flat scale at week 8 warrants a closer look, not panic.

Is it time to increase the dose?expand_more

Often yes, if you are tolerating your current dose and have been on it for at least 4 weeks. Your provider will weigh side effects and your overall response.

Could there be a medical reason I'm not losing?expand_more

Sometimes — thyroid issues, PCOS, certain antidepressants and antipsychotics, and chronic inflammation can all dampen GLP-1 response. Worth a brief workup if no obvious lifestyle cause shows up.

Should I stop the medication?expand_more

Almost never at week 8. The medication has often not yet reached its target dose. Most people who appear to be non-responders at week 8 do lose weight by week 16 with patience and titration.

Keep exploring

Browse all GLP-1 guides or read about dosing schedules.